Literature DB >> 21797842

2'-Methoxy-6-methylflavone: a novel anxiolytic and sedative with subtype selective activating and modulating actions at GABA(A) receptors.

Nasiara Karim1, John Curmi, Navnath Gavande, Graham Ar Johnston, Jane R Hanrahan, M Louise Tierney, Mary Chebib.   

Abstract

BACKGROUND AND
PURPOSE: Flavonoids are known to have anxiolytic and sedative effects mediated via actions on ionotropic GABA receptors. We sought to investigate this further. EXPERIMENTAL APPROACH: We evaluated the effects of 2'-methoxy-6-methylflavone (2'MeO6MF) on native GABA(A) receptors in new-born rat hippocampal neurons and determined specificity from 18 human recombinant GABA(A) receptor subtypes expressed in Xenopus oocytes. We used ligand binding, two-electrode voltage clamp and patch clamp studies together with behavioural studies. KEY
RESULTS: 2'MeO6MF potentiated GABA at α2β1γ2L and all α1-containing GABA(A) receptor subtypes. At α2β2/3γ2L GABA(A) receptors, however, 2'MeO6MF directly activated the receptors without potentiating GABA. This activation was attenuated by bicuculline and gabazine but not flumazenil indicating a novel site. Mutation studies showed position 265 in the β1/2 subunit was key to whether 2'MeO6MF was an activator or a potentiator. In hippocampal neurons, 2'MeO6MF directly activated single-channel currents that showed the hallmarks of GABA(A) Cl(-) currents. In the continued presence of 2'MeO6MF the single-channel conductance increased and these high conductance channels were disrupted by the γ2(381-403) MA peptide, indicating that such currents are mediated by α2/γ2-containing GABA(A) receptors. In mice, 2'MeO6MF (1-100 mg·kg(-1) ; i.p.) displayed anxiolytic-like effects in two unconditioned models of anxiety: the elevated plus maze and light/dark tests. 2'MeO6MF induced sedative effects at higher doses in the holeboard, actimeter and barbiturate-induced sleep time tests. No myorelaxant effects were observed in the horizontal wire test. CONCLUSIONS AND IMPLICATIONS: 2'MeO6MF will serve as a tool to study the complex nature of the activation and modulation of GABA(A) receptor subtypes.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21797842      PMCID: PMC3312486          DOI: 10.1111/j.1476-5381.2011.01604.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  58 in total

1.  Molecular and neuronal substrate for the selective attenuation of anxiety.

Authors:  K Löw; F Crestani; R Keist; D Benke; I Brünig; J A Benson; J M Fritschy; T Rülicke; H Bluethmann; H Möhler; U Rudolph
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  Guide to Receptors and Channels (GRAC), 5th edition.

Authors:  Stephen P H Alexander; Alistair Mathie; John A Peters
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

Review 3.  Insights into the biophysical properties of GABA(A) ion channels: modulation of ion permeation by drugs and protein interactions.

Authors:  M Louise Tierney
Journal:  Biochim Biophys Acta       Date:  2010-11-30

Review 4.  Modulation of GABA(A) receptors by natural products and the development of novel synthetic ligands for the benzodiazepine binding site.

Authors:  Jakob Nilsson; Olov Sterner
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

Review 5.  GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.

Authors:  John R Atack
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 6.  GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.

Authors:  John R Atack
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

7.  Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

Authors:  U Rudolph; F Crestani; D Benke; I Brünig; J A Benson; J M Fritschy; J R Martin; H Bluethmann; H Möhler
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

8.  Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice.

Authors:  R M Mihalek; P K Banerjee; E R Korpi; J J Quinlan; L L Firestone; Z P Mi; C Lagenaur; V Tretter; W Sieghart; S G Anagnostaras; J R Sage; M S Fanselow; A Guidotti; I Spigelman; Z Li; T M DeLorey; R W Olsen; G E Homanics
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

9.  Retrochalcone derivatives are positive allosteric modulators at synaptic and extrasynaptic GABA(A) receptors in vitro.

Authors:  Ruotian Jiang; Akiko Miyamoto; Adeline Martz; Alexandre Specht; Hitoshi Ishibashi; Marie Kueny-Stotz; Stefan Chassaing; Raymond Brouillard; Lia Prado de Carvalho; Maurice Goeldner; Junichi Nabekura; Mogens Nielsen; Thomas Grutter
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

10.  Molecular targets for the myorelaxant action of diazepam.

Authors:  F Crestani; K Löw; R Keist; M Mandelli; H Möhler; U Rudolph
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

View more
  10 in total

1.  Hepatoprotective activity of viscosine is mediated by attenuation of hepatic macrophages and iNOS expression in CCl4-intoxicated rats.

Authors:  Hamid Ali; Nurul Kabir; Muhammad Raza Shah; Akhtar Muhammad; Safdar Ali; Shahab Mehmood; Amjad Ali; Abid Ali; Azra Jahan
Journal:  Toxicol Res (Camb)       Date:  2016-09-13       Impact factor: 3.524

2.  Modulation of ionotropic GABA receptors by 6-methoxyflavanone and 6-methoxyflavone.

Authors:  Belinda J Hall; Nasiara Karim; Mary Chebib; Graham A R Johnston; Jane R Hanrahan
Journal:  Neurochem Res       Date:  2013-09-29       Impact factor: 3.996

3.  The flavonoid, 2'-methoxy-6-methylflavone, affords neuroprotection following focal cerebral ischaemia.

Authors:  Andrew N Clarkson; Lily Boothman-Burrell; Zita Dósa; Raghavendra Y Nagaraja; Liang Jin; Kim Parker; Petra S van Nieuwenhuijzen; Silke Neumann; Emma K Gowing; Navnath Gavande; Philip K Ahring; Mai M Holm; Jane R Hanrahan; Joseph A Nicolazzo; Kimmo Jensen; Mary Chebib
Journal:  J Cereb Blood Flow Metab       Date:  2018-01-29       Impact factor: 6.200

4.  Anticonvulsant, Anxiolytic, and Sedative Activities of Verbena officinalis.

Authors:  Abdul Waheed Khan; Arif-Ullah Khan; Touqeer Ahmed
Journal:  Front Pharmacol       Date:  2016-12-21       Impact factor: 5.810

5.  Anti-nociceptive and Anti-inflammatory Activities of Asparacosin A Involve Selective Cyclooxygenase 2 and Inflammatory Cytokines Inhibition: An in-vitro, in-vivo, and in-silico Approach.

Authors:  Nasiara Karim; Inamullah Khan; Waheed Khan; Imran Khan; Ajmal Khan; Sobia Ahsan Halim; Hizbullah Khan; Javid Hussain; Ahmed Al-Harrasi
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

Review 6.  Flavonoids as GABAA receptor ligands: the whole story?

Authors:  Cristina Wasowski; Mariel Marder
Journal:  J Exp Pharmacol       Date:  2012-02-23

7.  GABA-A Receptor Modulation and Anticonvulsant, Anxiolytic, and Antidepressant Activities of Constituents from Artemisia indica Linn.

Authors:  Imran Khan; Nasiara Karim; Waqar Ahmad; Abeer Abdelhalim; Mary Chebib
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-07       Impact factor: 2.629

8.  Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface.

Authors:  Ahmad Tarmizi Che Has; Nathan Absalom; Petra S van Nieuwenhuijzen; Andrew N Clarkson; Philip K Ahring; Mary Chebib
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

9.  The Direct Actions of GABA, 2'-Methoxy-6-Methylflavone and General Anaesthetics at β3γ2L GABAA Receptors: Evidence for Receptors with Different Subunit Stoichiometries.

Authors:  Han Chow Chua; Nathan L Absalom; Jane R Hanrahan; Raja Viswas; Mary Chebib
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

Review 10.  Phenolics as GABAA Receptor Ligands: An Updated Review.

Authors:  José-Luis Ríos; Guillermo R Schinella; Inés Moragrega
Journal:  Molecules       Date:  2022-03-08       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.